Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
23
NCT02370303
A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
Phase: N/A
Role: Collaborator
Start: Aug 31, 2014
Completion: Jul 9, 2016